Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways

Srimanta Patra,Prakash Priyadarshi Praharaj,Debasna Pritimanjari Panigrahi,Biswajit Panda,Chandra Sekhar Bhol,Kewal Kumar Mahapatra,Soumya Ranjan Mishra,Bishnu Prasad Behera,Mrutyunjay Jena,Gautam Sethi,Shankargouda Patil,Samir Kumar Patra,Sujit Kumar Bhutia

DOI: https://doi.org/10.1007/s11033-020-05709-8

IF: 2.7422

2020-08-14

Molecular Biology Reports

Abstract:Marine invertebrates are extremely diverse, largely productive, untapped oceanic resources with chemically unique bioactive lead compound contributing a wide range of screening for the discovery of anticancer compounds. The lead compounds have unfurled an extensive array of pharmacological properties owing to the presence of polyphenols, alkaloids, terpenoids and other secondary metabolites. The antioxidant, immunomodulatory and anti-tumor activities exhibited, are possibly regulated by the apoptosis induction, scavenging of ROS and modulation of cellular signaling pathways to defy the cellular deafness during carcinogenesis. Despite the enriched bioactive compounds, the marine invertebrates are largely unexplored as identification, screening, pre-clinical and clinical assessment of lead compounds and their synthetic analogs remain a major task to be solved. In the current review, we focus on the principle strategy and underlying mechanisms deployed by the bioactive anticancer compounds derived from marine invertebrates to combat cancer with special insight into the cell death mechanism.

biochemistry & molecular biology